by Csequence | Jul 28, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News July 8th – July 15th, 2022 Cannabidiol Derivative & Traumatic Brain Injury (TBI) VCE-004.8 demonstrated anti-inflammatory and protective effects, suggesting that this compound could open new therapeutic avenues for the treatment of TBI....by Csequence | Jul 28, 2022 | Communications, Weekly Cannabis News
July 1st – July 8th, 2022 The Use of Medical Cannabis as an Alternative Agent for Opioids in Managing Musculoskeletal Pain A new study found that patients suffering from musculoskeletal pain conditions reported notable reductions in pain after using medical cannabis...by Csequence | Jul 26, 2022 | Communications, Weekly Cannabis News
July 15th-July 22nd, 2022 Do Flavonoids Have a Future Role in the Treatment of Bladder Cancer? The flavonoid cannflavin A in combination with phytocannabinoids may be a better treatment strategy compared to chemotherapeutic agents, a new study suggests. Bladder cancer...by Csequence | Jul 21, 2022 | Communications, Weekly Cannabis News
June 24th – July 1st, 2022 CannTeen Study Results: Implications of Cannabis Use During Adolescence Results from the study showed that adolescent users were significantly more likely to have severe cannabis use disorder (CUD) compared to adult users, raising the...